Viking Therapeutics, Inc. · NASDAQ:VKTX
Vanguard Capital Management LLC reported a 5.08% stake in Viking Therapeutics, Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed Apr 30, 2026
Vanguard Capital Management LLC reported a 5.08% stake in Viking Therapeutics, Inc., 5,877,263 shares, as a passive investor on Mar 31, 2026. Filed Apr 30, 2026 (Schedule 13G).
- Stake
- 5.08%
- Shares
- 5,877,263
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vanguard Capital Management | 5.08% | 5,877,263 |
Source
Related
- Viking Therapeutics, Inc.
- Vanguard Capital Management LLC
- Viking Therapeutics, Inc. shareholders
- Form 4 · Kelly-Gemmell Dorothy Elizabeth · Aug 7, 2026
- Form 4 · Lian Brian · Jul 29, 2026
- Form 4 · Zante Greg · Jul 29, 2026
- Form 4 · Mancini Marianna · Jul 29, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026